Dietary Supplements May Delay Aging in Animal Models
Patients with Werner Syndrome age significantly earlier than others. In animal models for the disease – roundworms and banana flies – supplements of the drug NAD+ prolong life and delay age-related diseases. This is shown in new research from the Center for Healthy Aging, the University of Copenhagen, and the US National Institutes of Health, just published in Nature Communications. It also shows that Werner patients have less NAD+ in the blood. The results are so promising that clinical trials of patients with Werner Syndrome are on the way.
We are getting older and older, but some diseases mean that the patients age far too early and therefore live significantly shorter than the average. One of these types of diseases is Werner Syndrome. Patients with Werner Syndrome have early signs of aging, such as grey hair, wrinkled skin, increased incidence of cancer and type 2 diabetes. On average, they die at the age of 45. The underlying mechanisms of the disease are unknown and therefore, no treatment is yet available.
In a new study in the scientific journal Nature Communications, an international team of researchers from, among others, the University of Copenhagen and the National Institutes of Health in the United States, has come closer to a new way of attacking the disease. The researchers have looked at a clean-up process in the cells called mitophagy. Mitophagy breaks down defective mitochondria – the cell's energy factories – and reuses the proteins that they are made up of.
An Error in the Clean-Up Process
‘We are showing for the first time that Werner Syndrome is due to errors in the clean-up process. When we improve the clean-up by giving supplements of the drug NAD+, we can show in animal models that it increases lifespan and delays the aging processes’, says Professor Vilhelm Bohr from the Center for Healthy Aging, the University of Copenhagen, and the National Institutes of Health, who had led the study.
The researchers have looked closely at the clean-up processes in blood samples from patients with Werner Syndrome, in banana flies and in roundworms with the syndrome. In addition, they have also tested NAD+ in the animal models.
‘It strongly reinforces our findings that the clean-up process seems to be important in both human cells and across different animals. And then it is encouraging that in living animals, we can improve lifespan and delay the aging processes which are the key symptoms of Werner Syndrome’, says Vilhelm Bohr.
Good News for Patients with Werner Syndrome
Werner Syndrome is most common in Japan, where between 1 in 20,000 and 1 in 40,000 people suffer from the disease. In the United States, it is 1 in 200,000.
‘Our results are so promising that we have received inquiries from Japan with a view to performing clinical studies of patients with Werner Syndrome. We very much hope that the studies will point in the same direction so that patients can live longer and with a higher quality of life’, says Professor Vilhelm Bohr.
The study also helps to understand the mechanisms of aging, as aging processes in patients with Werner Syndrome are similar to what you normally see, except that the aging happens significantly earlier. In the long term, the new knowledge can therefore also help to delay the normal aging of the body and improve the quality of life in old age.
The study is supported by, amongst others, Helse Sør Øst RHF, the Research Council of Norway and the German Research Foundation. The research at the Center for Healthy Aging is supported by the Danish foundation Nordea-fonden. The researchers behind the study have a research and development agreement with ChromaDex, Aladdin Healthcare Technologies and the Vancouver Dementia Prevention Centre.
Read the entire study ‘NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome’ in Nature Communications.
Professor Vilhelm Bohr
Center for Healthy Aging and National Institutes of Health
Telephone: +1 443 850 4026
Press Officer Gitte Frandsen
Center for Healthy Aging
Mobile: +45 51 29 80 05